Ultragenyx press releases
The latest press releases from Ultragenyx (NASDAQ: RARE), gathered from its own newsroom and from the newswires that carry it. PPN World follows 1,400+ press release feeds and adds each Ultragenyx release within minutes of publication.
- Listing
- NASDAQ: RARE
- Latest release
- Nov 6, 2026
- On this page
- 7 newest releases
Latest Ultragenyx press releases
- Ultragenyx Announces the Marketing Authorisation Application (MAA) for its Investigational Gene Therapy for MPS IIIA (Sanfilippo syndrome Type A) is Under Review with the UK Medicines and Healthcare Products Regulatory Agency (MHRA)
BASEL, Switzerland, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Ultragenyx (NASDAQ:RARE), a biopharmaceutical company focused on the development and commercialisation of novel therapies for rare and ultra-rare…
- Ultragenyx Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $210 Million
NOVATO, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has entered into a definitive agreement to sell a Rare Pediatric Disease Priorit…
- Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NOVATO, Calif., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rar…
The first 3 are open to everyone. A free account shows the rest and emails you the next Ultragenyx release the minute it is out.
PPN World is independent and not affiliated with Ultragenyx. Headlines and short excerpts only; each release links to its source.
Questions
Where can I find Ultragenyx press releases?+
How do I get an alert when Ultragenyx publishes a press release?+
Is this Ultragenyx's official newsroom?+
Know the minute Ultragenyx publishes
Watch Ultragenyx, its competitors and its sector in one live feed, with email alerts — on the free plan.